Opinion|Videos|June 13, 2024
Non-Pharmacologic Interventions for Pediatric Patients with Narcolepsy
Experts on narcolepsy offer perspectives on non-pharmacologic interventions for pediatric patients with narcolepsy, including lifestyle changes.
Advertisement
Episodes in this series
Advertisement
Related to this article
Seaport begins phase 2a trial of GlyphAgo for generalized anxiety disorder with sleep disturbance, testing liver-sparing agomelatine dosing and tracking sleep, anxiety outcomes.
Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Olanzapine LAI (Weltruza) Receives FDA Approval for Schizophrenia
2
Moving Away From Treatment-Resistant Depression and Toward Difficult-to-Treat Depression
3
Two New MDD Approvals: 5-HT1A Agonism and Adjunctive Atypical Antipsychotics
4
Measurement-Informed Psychiatric Care: If Not Now, Then When?
5